Search company, investor...

Total Raised

$544M

Investors Count

6

Deal Terms

3

Investments

1

Funding, Valuation & Revenue

6 Fundings

Abnormal has raised $544M over 6 rounds.

Abnormal's latest funding round was a Series D for $250M on August 6, 2024.

Abnormal's valuation in May 2022 was $4,000M.

Abnormal's latest post-money valuation is from August 2024.

Sign up for a free demo to see Abnormal's valuations in August 2024, November 2020 and more.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

8/6/2024

Series D

$250M

$XXM

0

FY undefined

6

3/29/2023

Series C - II

$XXM

$XXM

0

FY undefined

10

5/10/2022

Series C

$XXM

$4,000M

0

FY undefined

10

11/18/2020

Series B

$XXM

$XXM

0

FY undefined

10

11/18/2019

Series A - II

$XXM

$XXM

0

FY undefined

10

Date

8/6/2024

3/29/2023

5/10/2022

11/18/2020

11/18/2019

Round

Series D

Series C - II

Series C

Series B

Series A - II

Amount

$250M

$XXM

$XXM

$XXM

$XXM

Investors

Valuation

$XXM

$XXM

$4,000M

$XXM

$XXM

Revenue

0

FY undefined

0

FY undefined

0

FY undefined

0

FY undefined

0

FY undefined

Sources

6

10

10

10

10

You're one click away from the most comprehensive, unmatched analyst expertise in tech, in-depth private company data and a platform that brings it all together.
Click Now. Join a live demo
Join a demo
CB Insights
Looking for a leg up on competitive, customer and technology insights?
CB Insights puts confidence and clarity into your most strategic decisions.
See how. Join a demo.
Join a demo
Trusted by the world's smartest companies to:
  • Predict emerging trends
  • See competitors' playbooks
  • Stalk the smart money
  • Identify tomorrow's challengers
  • Spot growing industries
  • Kill analyst data work
Let's see how we can help you!
MicrosoftWalmartWells Fargo

Abnormal Deal Terms

3 Deal Terms

Abnormal's deal structure is available for 3 funding rounds, including their Series D from August 06, 2024.

Round

Series D

Series C

Series B

Funding Date

$XXM

$XXM

$XXM

Pre-Money Valuation

$XXM

$XXM

$XXM

Post-Money Valuation

$XXM

$XXM

$XXM

Amount Raised

$XXM

$XXM

$XXM

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

$XXM

$XXM

$XXM

Board Voting

$XXM

$XXM

$XXM

Par Value

Round

Funding Date

Pre-Money Valuation

Post-Money Valuation

Amount Raised

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

Board Voting

Par Value

Series D

$XXM

$XXM

$XXM

$XXM

$XXM

$XXM

Series C

$XXM

$XXM

$XXM

$XXM

$XXM

$XXM

Series B

$XXM

$XXM

$XXM

$XXM

$XXM

$XXM

Abnormal Investors

6 Investors

Abnormal has 6 investors. Greylock Partners invested in Abnormal's Series D funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

4/13/2018

8/6/2024

5
Series A, Series A - II (2019), Series B (2020), Series C (2022), Series D (2024)

Venture Capital

California

00/00/0000

00/00/0000

Menlo Ventures

Subscribe to see more

Venture Capital

California

00/00/0000

00/00/0000

CrowdStrike Falcon Fund

Subscribe to see more

Corporate Venture

California

00/00/0000

00/00/0000

Insight Partners

Subscribe to see more

Private Equity

New York

00/00/0000

00/00/0000

Wellington Management

Subscribe to see more

Asset/Investment Management

Massachusetts

First funding

4/13/2018

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Last Funding

8/6/2024

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Investor

Menlo Ventures

CrowdStrike Falcon Fund

Insight Partners

Wellington Management

Rounds

5
Series A, Series A - II (2019), Series B (2020), Series C (2022), Series D (2024)

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Board Seats

Type

Venture Capital

Venture Capital

Corporate Venture

Private Equity

Asset/Investment Management

Location

California

California

California

New York

Massachusetts

Abnormal Investments

1 Investments

Abnormal has made 1 investments. Their latest investment was in Terzo as part of their Seed VC on August 13, 2021.

CBI Logo

Abnormal Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

8/13/2021

Seed VC

Terzo

$3.2M

Yes

4

Date

8/13/2021

Round

Seed VC

Company

Terzo

Amount

$3.2M

New?

Yes

Co-Investors

Sources

4

CB Insights
Looking for a leg up on competitive, customer and technology insights?
CB Insights puts confidence and clarity into your most strategic decisions.
See how. Join a demo.
Join a demo
Trusted by the world's smartest companies to:
  • Predict emerging trends
  • See competitors' playbooks
  • Stalk the smart money
  • Identify tomorrow's challengers
  • Spot growing industries
  • Kill analyst data work
Let's see how we can help you!
MicrosoftWalmartWells Fargo

Compare Abnormal to Competitors

Mimecast Logo
Mimecast

Mimecast focuses on organizational security and operates in the cybersecurity industry. The company offers advanced solutions for proactive threat detection, email and collaboration security, and provides training and tools for brand protection and data retention. These services cater to the needs of modern workplaces looking to mitigate risks associated with cyberattacks, human error, and technological vulnerabilities. It was founded in 2003 and is based in London, United Kingdom. Mimecast operates as a subsidiary of Permira.

Valimail Logo
Valimail

Valimail focuses on identity-based anti-phishing solutions within the cybersecurity industry. The company offers a cloud-native platform for validating and authenticating sender identity to prevent phishing, protect brands, and ensure compliance. Its main services include monitoring, enforcing, and amplifying email security protocols to provide continuous protection of domains. It was founded in 2015 and is based in San Francisco, California.

X
Xorlab

Xorlab is a cybersecurity company focused on providing enhanced email security solutions. Their main offerings include a data-driven platform that adapts to an organization's specific context to protect against sophisticated email threats such as phishing, business email compromise (BEC), and ransomware. Xorlab's security platform is designed to learn communication patterns and apply contextual analysis to effectively identify and mitigate potential threats. It was founded in 2015 and is based in Zurich, Switzerland.

IRONSCALES Logo
IRONSCALES

IRONSCALES provides an artificial intelligence-driven email security platform. The company offers ransomware protection, credential theft protection, account takeover protection, security awareness training, phishing stimulation testing, and more. It primarily serves the cybersecurity industry. The company was founded in 2014 and is based in Atlanta, Georgia.

INKY Logo
INKY

INKY is a company focused on behavioral email security within the cybersecurity industry. Its main offerings include a cloud-based platform that scans inbound, internal, and outbound emails to block phishing, malware, and prevent data leaks, while also providing real-time guidance to users. The company primarily serves sectors that require robust email security solutions, such as finance, healthcare, and technology services. INKY was formerly known as New Arcode. It was founded in 2008 and is based in College Park, Maryland.

SlashNext Logo
SlashNext

SlashNext is a cybersecurity company specializing in integrated cloud messaging security across various platforms. The company offers protection against business email compromise (BEC), smishing, account takeovers, and zero-hour phishing attacks for email, mobile, and web browsers. SlashNext's solutions are designed to secure communication channels such as Microsoft 365, Zoom, SMS, LinkedIn, WhatsApp, and more, utilizing advanced technologies like AI for threat detection and prevention. It was founded in 2017 and is based in Pleasanton, California.

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.